Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Proceedings of the American Thoracic Society 4:9-17 (2007)
© 2007 The American Thoracic Society
doi: 10.1513/pats.200608-156JG

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guo, Y.
Right arrow Articles by Van Eyk, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guo, Y.
Right arrow Articles by Van Eyk, J. E.

A Proteomic Primer for the Clinician

Yurong Guo, Zongming Fu and Jennifer E. Van Eyk

Departments of Medicine, Biological Chemistry, and Biomedical Engineering, The Johns Hopkins University, Baltimore, Maryland

Correspondence and requests for reprints should be addressed to Yurong Guo, Ph.D., Johns Hopkins University Bayview Campus, 5200 Eastern Avenue, Mason F. Lord Building, Center tower, Room 609, Baltimore, MD 21224. E-mail: yguo7{at}jhmi.edu

ABSTRACT

Proteomics is a rapidly developing field and it opens new horizons in many research areas of life sciences. In the field of medicine, proteomics promises to accelerate the discovery of new drug targets and protein disease markers useful for in vitro diagnosis. In this article, we review the current proteomics technologies for biomarker discovery and validation, which include two-dimensional gel electrophoresis, one- and two-dimensional liquid chromatography, and proteomic microarrays. We will also review proteomic strategies for protein–protein interactions and identification of post-translational modifications. Selection of the more effective technology or combination of technologies is required to maximize the interpretation and utility of the data.

Key Words: 2D electrophoresis • multiple dimensional chromatography • post-translational modification • proteomic microarrays • proteomics




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
P. Matt, Z. Fu, Q. Fu, and J. E. Van Eyk
Biomarker discovery: proteome fractionation and separation in biological samples
Physiol Genomics, October 8, 2008; 33(1): 12 - 17.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Thoracic Society.
 
ATS 2008 State of the Art Course